Medscape Education is a proud sponsor of the 2025 SDNP National Conference, taking place from April 30 to May 3 at the ...

AI is revolutionising the pharmaceutical industry, as highlighted at Reuters Pharma 2025, with transformative applications ...

Merck KGaA has announced that it will be acquiring SpringWorks Therapeutics for approximately $3.9bn. The definitive ...

Roche has become the latest major drugmaker to announce a significant investment in the US, committing $50bn into the country ...

The phase 3 CREST trial has been assessing the subcutaneously-administered drug in combination with standard-of-care Bacillus ...

The answer is yes, pharma can have an impact We can and should use our expertise and resources to tackle misinformation.

Generics account for 81% of U.K. primary care prescriptions but just 28% of NHS medicines spending, delivering significant ...

Medscape Education is honored to be a Friend of COA sponsor at the Community Oncology Conference, taking place from April 28-30th in Orlando, FL. This ...

Johnson & Johnson (J&J) has announced that its dual-acting IL-23 inhibitor Tremfya (guselkumab) has been approved by the ...

Boehringer Ingelheim and Tessellate Bio have entered into a partnership worth over €500m to develop oral precision medicines ...

Ipsen’s elafibranor has shown promise as a treatment for primary sclerosing cholangitis (PSC), a rare liver disease that ...

But the legal and regulatory framework is evolving to keep pace. The EU AI Act, GDPR and medical device regulations are ...